Scope Biosciences

Developer of CRISPR-Cas based diagnostic platform

placeWageningen, Gelderland, Netherlands calendar_todayFounded 2019 groups8 employees language scopebio.com

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 56 times.

YearFilings
20241
20251

Social engagement

Social engagement: 2.3K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Tech Transfer, Oost NL, GenDx.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%

Recent activity

15 Jun 2026
Leadership hire
CEO
7 Jan 2026
Event
Aardbeiendag / International Soft Fruit Conference
10 Sep 2025
Milestone
cert
Coming soon